TaperCommunity
Tinnitus from medication withdrawal is one of the more disorienting symptoms people report when coming off antidepressants, benzodiazepines, and certain other psychiatric drugs. The ringing, hissing, or buzzing can start within days of a dose reduction and linger for weeks or months. It is not imagined, and it is not rare. Surveys of long-term SSRI and benzodiazepine users consistently find auditory disturbances among the symptoms most likely to surface during tapering. Understanding why this happens, how long it tends to last, and what actually helps can make the experience less frightening, even when the noise itself does not stop on command.
Tinnitus is the perception of sound when no external source is present. In the context of medication withdrawal, it typically appears as a high-pitched ringing in one or both ears, though some people describe it as hissing, humming, pulsing, or a low rumble. It can be constant or come in waves, and it often gets louder in quiet rooms or at night.
The mechanism is not fully mapped, but the leading hypothesis involves changes in the brain's central auditory processing rather than damage to the ear itself. Long-term use of drugs that act on GABA, serotonin, or noradrenaline systems alters how the auditory cortex filters sound. When the drug is removed, that filtering becomes erratic, and the brain generates phantom signals to fill the gap.
Tinnitus from medication withdrawal is most commonly reported with benzodiazepines, SSRIs and SNRIs, gabapentinoids, and Z-drugs like zolpidem. The Ashton Manual, the long-standing reference text on benzodiazepine withdrawal, lists tinnitus as one of the more persistent symptoms in protracted cases. SSRI discontinuation studies, including work by Horowitz and Taylor, document similar auditory complaints when tapers are too fast.
For most people, the noise fades as the nervous system stabilizes. For a smaller group, it persists longer, sometimes for a year or more. Knowing which category you are likely to fall into is impossible in advance, which is part of what makes this symptom so hard to sit with.
Benzodiazepines have the longest paper trail when it comes to withdrawal tinnitus. Drugs like Klonopin, Xanax, and Ativan suppress neuronal excitability through GABA-A receptors. When that suppression is lifted faster than the brain can adjust, the auditory system, which depends heavily on inhibitory tone, can become hyperactive.
SSRIs and SNRIs are the next most reported category. Lexapro, Zoloft, Effexor, and Cymbalta have all been associated with tinnitus during and after discontinuation. Effexor in particular is notorious because of its short half-life, which makes withdrawal symptoms appear quickly and intensely if doses are missed or cut too steeply.
Gabapentin and pregabalin, prescribed for nerve pain, anxiety, and off-label sleep issues, can produce tinnitus during withdrawal through their effects on calcium channel signaling and indirect GABAergic modulation. Z-drugs like zolpidem and zopiclone behave similarly to benzodiazepines at the receptor level and carry the same risk profile for auditory symptoms.
Antipsychotics, mood stabilizers, and certain blood pressure medications are reported less often but do appear in case reports. The pattern across all of these is consistent: drugs that quiet the central nervous system can leave the auditory system temporarily over-amplified when they are removed.
The single biggest predictor of withdrawal tinnitus severity, based on patient-reported data and the clinical literature, is how quickly the dose came down. The Maudsley Deprescribing Guidelines, published in 2024, formalized what experienced clinicians and patient communities had been saying for years: receptor occupancy does not decline in a straight line as you reduce a dose. Cutting a drug in half does not halve its effect on the brain. The relationship is hyperbolic, meaning the last small amounts of drug have a disproportionately large impact.
This is why people often sail through the first several reductions and then hit a wall near the bottom of the dose. The auditory symptoms that appear in this late phase are often the most stubborn. A taper that respects the hyperbolic curve, with smaller and smaller absolute reductions as the dose decreases, tends to produce fewer and milder symptoms.
The general principle is to slow down rather than push through. When tinnitus appears or worsens, that is information from your nervous system. Treating it as a signal rather than an obstacle changes how you respond. Holding at the current dose until symptoms settle, then resuming reductions at a gentler pace, is the approach most withdrawal-aware clinicians recommend.
This article does not prescribe specific reduction percentages because the right pace depends on the drug, the individual, and the history of prior cuts. Working with a prescriber who understands hyperbolic tapering, or learning the principles deeply enough to advocate for them, is the practical path forward.
There is no universal timeline, but patterns emerge from the available data. Acute withdrawal tinnitus, the kind that appears within days of a dose change, often resolves within two to eight weeks once the dose is stabilized or the taper is slowed. This is the most common course.
Protracted cases, where tinnitus persists for months after the last dose, are less common but well documented. Benzodiazepine withdrawal protracted syndrome can include tinnitus lasting six to eighteen months in a subset of long-term users. SSRI post-acute withdrawal symptoms can follow a similar long arc.
The encouraging news, repeated in survivor surveys and longitudinal follow-ups, is that improvement continues over time even when it feels stalled. People who report tinnitus at six months off a drug usually report less of it at twelve months, and less again at twenty-four. The brain rebuilds inhibitory tone slowly, and the auditory cortex recalibrates along with it.
Tinnitus that began before any medication change, or that started decades earlier and only became noticeable during withdrawal, is a different situation. Withdrawal can unmask pre-existing tinnitus rather than cause it. Distinguishing the two matters for managing expectations, though the coping strategies overlap.
The first principle is reducing the nervous system load wherever possible. Sleep, when achievable, is the strongest single intervention. Tinnitus loudness and distress both worsen with sleep deprivation, and they both improve when sleep is restored. Establishing a quiet, dark, cool sleep environment and protecting the same bedtime each night is unglamorous but consistently effective.
Sound enrichment is the next layer. Complete silence makes phantom sound louder by contrast. Low-level background noise, whether from a fan, a white noise machine, or a recording of rain or ocean, gives the auditory system something real to process. Many people find that pink noise or brown noise works better than white noise because the frequency profile is gentler.
Stress management is not optional. The autonomic nervous system and the auditory system are tightly linked, and any sustained activation of the fight-or-flight response makes tinnitus louder. Slow nasal breathing, walking outdoors, time away from screens, and limited caffeine all help in ways that compound over weeks.
Cognitive behavioral therapy specifically adapted for tinnitus, often called tinnitus retraining therapy or CBT for tinnitus, has the strongest evidence base of any psychological intervention. It does not eliminate the sound, but it reliably reduces the distress the sound causes, and over time the perceived loudness often drops as well. NHS and American Academy of Audiology guidelines both recommend it as a first-line approach for chronic tinnitus.
Withdrawal tinnitus does not require imaging or extensive testing in most cases, but there are situations where an audiology workup is genuinely useful. New tinnitus that is one-sided, pulsatile, or accompanied by hearing loss should be evaluated to rule out structural causes that are unrelated to the medication. Sudden hearing changes, vertigo, or ear pain also warrant prompt assessment.
A baseline audiogram, even a normal one, can be reassuring. It establishes that the auditory pathway itself is intact, which makes the central nervous system explanation more credible and helps with treatment planning. Audiologists who specialize in tinnitus can also fit sound therapy devices, including hearing aids with masking features, that can take the edge off severe cases.
What an audiology evaluation will not do is confirm whether your specific tinnitus is caused by medication withdrawal. There is no biomarker for that. The diagnosis is clinical, based on timing, drug history, and the absence of competing explanations. A thoughtful audiologist will acknowledge this rather than dismiss it.
Usually not. The large majority of people who develop tinnitus during a taper see it fade as the nervous system stabilizes, often within weeks to a few months. A smaller group experiences protracted symptoms lasting a year or more, and a still smaller group reports lasting changes. Predicting which group you fall into in advance is not possible, but most cases improve with time.
In acute withdrawal, particularly with benzodiazepines and short-half-life SSRIs, returning to the previous stable dose often reduces or resolves the symptom within days to weeks. The further out from the last dose you are, the less reliable reinstatement becomes. This is a decision to make carefully with a prescriber who understands withdrawal, not something to do on your own.
Increasing the dose above your current level to chase tinnitus relief is generally not advised. It can complicate the eventual taper and rarely produces lasting improvement. Stabilizing at the current dose and slowing further reductions is the safer approach.
No supplement has strong evidence for treating tinnitus specifically. Ginkgo, magnesium, and zinc have been studied with mixed and mostly disappointing results. Avoid adding new medications to manage the symptom without clear guidance from a prescriber, as introducing more centrally acting drugs can complicate an already sensitized nervous system.
Two reasons. Ambient noise drops in the evening, so the phantom sound becomes more prominent by contrast. And the nervous system winds down its outward focus, which turns attention inward toward bodily sensations including the tinnitus. Sound enrichment and consistent sleep timing address both.
Tinnitus from medication withdrawal is a real and recognized phenomenon, not a character flaw and not a sign that something is permanently broken. The evidence supports patience, gentler tapering, and the practical coping tools that quiet the nervous system rather than fight the sound directly.
If you are tapering and dealing with this, you are not alone, and the experience of others who have been through it is worth more than most medical pamphlets on the subject. Join the conversation at taper.community to share what is working, ask questions, and learn from people who have walked this road.
This article is for informational purposes only and is not medical advice. Decisions about starting, continuing, or stopping any medication should be made with a qualified prescriber who knows your full history.